A large study investigating mutation concordance within NSCLC primary tumours and between primary tumours and metastases or recurrences found no macroheterogeneity of EGFR driver mutations, further supporting the notion that activating EGFR mutations are generally truncal [23]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.